We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
» Health Canada Plans 3D Printing Guidance
Health Canada Plans 3D Printing Guidance
September 6, 2018
Devices
Regulatory Affairs
Health Canada is developing guidance to help devicemakers seeking to license 3D-printed medical devices.
To View This Article:
Login
Email
Password
Register
Remember Me
Forgot your password?
Subscribe To The GMP Letter
Buy This Article Now
Add this article to your cart for $40.00
Upcoming Events
23
Apr
Managing Data and Documentation for FDA Inspections and Remote Assessments
25
Apr
A Masterclass on Effective 483 Responses
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
30
May
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
CDER Seeks Innovative Clinical Trial Designs for Demo Project
FDA Needs $114M to Fund Federal Government Pay Increases, Agency CFO Says
Eugia Pharma Gets Three 483s Since January, Following Inspections of Plants in India
Abbott/Thoratec Heartmate LVAS Deaths Result in Class I Recall
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More